QUAY STEVEN C (President & CEO) received a stock award from ATOSSA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/22/2026ACC: 0001193125-26-019273
DirectorOfficer· President & CEO
Since Jan 2019
+1.28M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.28M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+325.20K
Price / share
—
Trade value
—
% of position
2339.9%
1/20/2026
13.90K→339.10K
Total
Net shares
+325.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | A · Award | +325.20K | — | — | 2339.9% | 13.90K | 339.10K |
| Total | +325.20K | $0.00 | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
950K shares
Shares
+950K
Strike price
0.603
Held after
950K
Exercisable
—
1/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock950K shares | 1/20/2026 | A · Award | +950K | 0.603 | — | 950K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned22.25K
Total
22.25K indirect22.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.25K | Indirect |
| Total | 22.25K | 22.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported